- Home
- CUB vs CVRX Comparison
CUB vs CVRX Comparison
Compare CUB & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUB
- CVRX
- Stock Information
- Founded
- CUB 2024
- CVRX 2000
- Country
- CUB United States
- CVRX United States
- Employees
- CUB N/A
- CVRX N/A
- Industry
- CUB
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CUB
- CVRX Health Care
- Exchange
- CUB NYSE
- CVRX Nasdaq
- Market Cap
- CUB 307.3M
- CVRX 311.3M
- IPO Year
- CUB 2024
- CVRX 2021
- Fundamental
- Price
- CUB $10.09
- CVRX $12.11
- Analyst Decision
- CUB
- CVRX Buy
- Analyst Count
- CUB 0
- CVRX 7
- Target Price
- CUB N/A
- CVRX $16.67
- AVG Volume (30 Days)
- CUB 60.5K
- CVRX 187.2K
- Earning Date
- CUB 01-01-0001
- CVRX 01-23-2025
- Dividend Yield
- CUB N/A
- CVRX N/A
- EPS Growth
- CUB N/A
- CVRX N/A
- EPS
- CUB N/A
- CVRX N/A
- Revenue
- CUB N/A
- CVRX $47,255,000.00
- Revenue This Year
- CUB N/A
- CVRX $31.78
- Revenue Next Year
- CUB N/A
- CVRX $26.42
- P/E Ratio
- CUB N/A
- CVRX N/A
- Revenue Growth
- CUB N/A
- CVRX 34.38
- 52 Week Low
- CUB $9.96
- CVRX $6.40
- 52 Week High
- CUB $10.55
- CVRX $33.14
- Technical
- Relative Strength Index (RSI)
- CUB N/A
- CVRX 38.54
- Support Level
- CUB N/A
- CVRX $12.57
- Resistance Level
- CUB N/A
- CVRX $13.68
- Average True Range (ATR)
- CUB 0.00
- CVRX 0.85
- MACD
- CUB 0.00
- CVRX -0.35
- Stochastic Oscillator
- CUB 0.00
- CVRX 17.11
About CUB LIONHEART HOLDINGS
Lionheart Holdings is a blank check company.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.